Two novel pancreatic cancer cell lines with highly metastatic activity were established and analyzed

March 27, 2019

Pancreatic cancer is one of the most lethal diseases in the world, with five-year-survival rate less than 9%. The poor prognosis of pancreatic cancer is related to several factors, including the early occurrence of metastatic disease. Only 20% of patients who are in a non-metastatic stage have chance to receive curative surgery, while the remainder are not eligible for surgery in an advanced or metastatic stage. It is therefore necessary to explore the mechanisms responsible for metastasis of pancreatic cancer to allow the development of effective therapeutic strategies. However, we lack effective models mimic the process of metastasis in vitro currently, which hinders our study on the molecular mechanism of tumor metastasis to some aspect.

On 13th March, 2019, the team of Pro. Yupei Zhao published an article in Science China Life Sciences entitled "Integrated analysis of gene expression and methylation profiles of novel pancreatic cancer cell lines with highly metastatic activity". This research established two human pancreatic cancer cell sublines with high metastasis potential, MIA PaCa-2 In8 and Panc-1 In8, by Matrigel induction assay. The established cell lines showed increased migration, invasion, wound-healing, and clonogenic abilities, compared with their parental cells in vitro. Following tail-vein injection in mouse models of lung metastasis, these two highly metastatic cell lines also demonstrated increased aggressiveness in vivo.

In addition, differential expression of mRNA, long non-coding RNA (lncRNA), micro RNA (miRNA), and methylation profiling were compared between the highly metastatic and parental cell lines, and the signaling pathways involved in the metastatic processes were also analyzed. A dysregulated lncRNA-miRNA-mRNA competitive endogenous RNAs (ceRNAs) network was constructed based on the above data, providing valuable material for future research on mechanisms.

It is worth mentioning that, although some highly metastatic pancreatic cancer cell lines have been reported previously, only few studies have established highly metastatic pancreatic cancer cell lines by induction. In the current study, researchers induced the invasion and migration abilities of two different pancreatic cancer cell lines, MIA PaCa-2 and Panc-1, using Matrigel, which consists of laminin, transforming growth factor-β, collagen IV, fibroblast growth factor, tissue fibroblast activating factor, and other growth factors, to mimic the extracellular matrix in vivo. Compared with previous methods that induced highly metastatic cancer cells in situ or in the caudal vein in vivo, this method achieved the same effect but was easier and more convenient.

In conclusion, the study established two highly metastatic pancreatic cancer lines, MIA PaCa-2 In8 and Panc-1 In8, from parental cell lines by Matrigel induction assay, and analyzed and compared the integrated mRNA, lncRNA, miRNA, and methylation profiles between the highly metastatic and parental cell lines, providing functional tools and solid material for future studies.
-end-
Yang G, Wang HY, Feng MY, You L, Zheng LF, Zhang TP, Cong L, Zhao YP (2019) Integrated analysis of gene expression and methylation profiles of novel pancreatic cancer cell lines with highly metastatic activity. Sci China Life Sci, doi: 10.1007/s11427-018-9495-2 http://engine.scichina.com/publisher/scp/journal/SCLS/doi/10.1007/s11427-018-9495-2?slug=fulltext

Science China Press

Related Pancreatic Cancer Articles from Brightsurf:

Precision chemo-immunotherapy for pancreatic cancer?
Pancreatic cancer is highly lethal: according to the National Cancer Institute, only about 10 percent of patients remain alive five years after diagnosis.

Nerves keep pancreatic cancer cells from starving
Pancreatic cancer cells avert starvation by signaling to nerves, which grow into dense tumors and secrete nutrients.

Pancreatic cancer: Subtypes with different aggressiveness discovered
To date, no targeted personalized therapies for pancreatic cancer exist.

Bringing the 'sticky' back to pancreatic cancer
A multidisciplinary team of researchers at Japan's Tohoku University has found that a gene regulator, called BACH1, facilitates the spread of pancreatic cancer to other parts of the body.

Does lung damage speed pancreatic cancer?
High levels of CO2 in the body, due to chronic respiratory disorders, may exacerbate pancreatic cancer, making it more aggressive and resistant to therapy.

Scientists have identified the presence of cancer-suppressing cells in pancreatic cancer
Researchers have identified cells containing a protein called Meflin that has a role in restraining the progression of pancreatic cancer.

Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth
A new discovery about pancreatic cancer sheds light on how the cancer fuels its growth and may help explain how promising cancer drugs work -- and for whom they will fail.

Overcoming resistance in pancreatic cancer
In pancreatic cancer cells' struggle to survive, the cells choose alternative routes when their main pathways are blocked by drugs.

Exposing how pancreatic cancer does its dirty work
Pancreatic cancer is a puzzle -- tumors slough off cells into the bloodstream early in the disease, but the tumors themselves have almost no blood vessels in them.

Targeting cell division in pancreatic cancer
Study provides new evidence of synergistic effects of drugs that inhibit cell division and support for further clinical trials.

Read More: Pancreatic Cancer News and Pancreatic Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.